The firm invests in disruptive legacy healthcare technologies and life sciences companies, and its Boomerang Venture Studio (BVS) de-risks key uncertainties, identifies new value drivers, and provides resources to first-time founders, universities, corporate clients, and healthcare systems. BVS combines company building with venture funding to compress time, iterate quickly, and scale faster. Boomerang Ventures' team has considerable corporate experience in the life science industry, and it provides its portfolio companies with access to capital from its Boomerang Venture Fund and extensive network of capital partners.